Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'CONDIOTTI R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Condiotti, R; Zakai, YB; Barak, V; Nagler, A
      Ex vivo expansion of CD56(+) cytotoxic cells from human umbilical cord blood

      EXPERIMENTAL HEMATOLOGY
    2. Nagler, A; Rabinowitz, R; Rosengolts-Rat, J; Condiotti, R; Schlesinger, M
      Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT)

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Nagler, A; Condiotti, R; Rabinowitz, R; Schlesinger, M; Nguyen, M; Terstappen, LWMM
      Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)

      MEDICAL ONCOLOGY
    4. Baraz, L; Kotler, M; Condiotti, R; Nagler, A
      Sensitization of resting T cells to autologous natural-killer-cell-mediated lysis by phytohemagglutinin

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    5. Baraz, L; Khazanov, E; Condiotti, R; Kotler, M; Nagler, A
      Natural killer (NK) cells prevent virus production in cell culture

      BONE MARROW TRANSPLANTATION
    6. BARAK V; CONDIOTTI R; ZAKAI YB; NAGLER A
      CYTOKINE LEVELS IN EX-VIVO EXPANDED CORD BLOOD-DERIVED NATURAL-KILLER(NK) CELLS

      European cytokine network
    7. CONDIOTTI R; NAGLER A
      EFFECT OF INTERLEUKIN-12 ON ANTITUMOR-ACTIVITY OF HUMAN UMBILICAL-CORD BLOOD AND BONE-MARROW CYTOTOXIC-CELLS

      Experimental hematology
    8. NAGLER A; CONDIOTTI R; NABET C; NAPARSTEK E; OR R; SAMUEL S; SLAVIN S
      SELECTIVE CD4(-CELL DEPLETION DOES NOT PREVENT GRAFT-VERSUS-HOST DISEASE() T)

      Transplantation
    9. MORECKI S; GELFAND Y; LEVI S; NAGLER A; CONDIOTTI R; NABET C; ACKERSTEIN A; SLAVIN S
      ACTIVATED LONG-TERM PERIPHERAL-BLOOD CULTURES AS PREPARATION FOR ADOPTIVE ALLOREACTIVE CELL THERAPY IN CANCER-PATIENTS

      Journal of hematotherapy
    10. NAGLER A; CONDIOTTI R; LUBINA A; DEUTSCH VR
      ENHANCEMENT OF MEGAKARYOCYTOPOIESIS BY CAMPATH-1G-TREATED NATURAL-KILLER-CELLS

      Bone marrow transplantation
    11. NAGLER A; KATZ A; AINGORN H; MIAO HQ; CONDIOTTI R; GENINA O; PINES M; VLODAVSKY I
      INHIBITION OF GLOMERULAR MESANGIAL CELL-PROLIFERATION AND EXTRACELLULAR-MATRIX DEPOSITION BY HALOFUGINONE

      Kidney international
    12. NAGLER A; OR R; NAPARSTEK E; AKER A; CONDIOTTI R; NABET C; SAMUEL S; SLAVIN S
      SELECTIVE CD4(-CELL DEPLETION DOES NOT PREVENT GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)() T)

      Experimental hematology
    13. NAGLER A; CONDIOTTI R; RABINOWITZ R; SCHLESINGER M; NGUYEN M; TERSTAPPEN LWMM
      DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) FOLLOWING BMT BY MULTIPARAMETER FLOW-CYTOMETRY (MPFC)

      Experimental hematology
    14. CONDIOTTI R; NAGLER A
      CAMPATH-1G IMPAIRS HUMAN NATURAL-KILLER (NK) CELL-MEDIATED CYTOTOXICITY

      Bone marrow transplantation
    15. CONDIOTTI R; SLAVIN S; NAGLER A
      ASTA-Z-7557 IMPAIRS HUMAN NATURAL-KILLER (NK) CELL-ACTIVITY

      Leukemia research
    16. CONDIOTTI R; SLAVIN S; BARAK V; NAGLER A
      THE NOVEL IMMUNOMODULATOR, LINOMIDE, STIMULATES INTERLEUKIN-2-INDUCEDHUMAN NATURAL-KILLER (NK) CELL AND PHA-STIMULATED T-CELL PROLIFERATION FROM NORMAL DONORS

      Leukemia research
    17. NAGLER A; LAZAROVITZ V; CONDIOTTI R; BRAUTBAR C; BISHARA A
      THE PUTATIVE ROLE OF HLA-C RECOGNITION BY NATURAL-KILLER (NK) CELLS IN GRAFT-VS-HOST DISEASE (GVHD) AND GRAFT-REJECTION POST-BONE MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    18. NAGLER A; RABINOWITZ R; ROSENGOLTS J; CONDIOTTI R; SCHLESINGER M
      THE DEVELOPMENTAL RELATIONSHIP BETWEEN NATURAL-KILLER (NK) AND T-CELLS POST-BONE MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    19. BISHARA A; AMAR A; BRAUTBAR C; CONDIOTTI R; LAZAROVITZ V; NAGLER A
      THE PUTATIVE ROLE OF HLA-C RECOGNITION IN GRAFT-VERSUS-HOST DISEASE (GVHD) AND GRAFT-REJECTION AFTER UNRELATED BONE-MARROW TRANSPLANTATION (BMT)

      Experimental hematology
    20. NAGLER A; BARAZ L; CONDIOTTI R; KOTLER M
      NATURAL-KILLER (NK) CELLS PREVENT VIRAL REPLICATION IN CELL-CULTURE

      Blood
    21. NAGLER A; SHUR I; OR R; BARAK V; CONDIOTTI R; FABIAN I
      GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR (GM-CSF) DEPENDENT MONOCYTE-MEDIATED CYTOTOXICITY POST-AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)

      Experimental hematology
    22. LEVISCHAFFER F; SEGAL V; BARAK V; RUBINCHIK E; CONDIOTTI R; NAGLER A
      MONONUCLEAR-CELLS REGULATE IN-VITRO MAST-CELL AND FIBROBLAST FUNCTIONAL-ACTIVITY IN MURINE AND HUMAN CHRONIC GRAFT-VS-HOST DISEASE

      Experimental hematology
    23. DEUTSCH VR; NAGLER A; SLAVIN S; CONDIOTTI R; LEVINE RF; ELDOR A
      EFFECT OF BONE-MARROW T-LYMPHOCYTES TREATED WITH CAMPATH 1G ON MEGAKARYOCYTE COLONY FORMATION

      Experimental hematology
    24. HARDAN I; CONDIOTTI R; CAHALON L; LIDER O; NAGLER A
      LOW-MOLECULAR-WEIGHT HEPARIN INHIBITS PROLIFERATION AND CYTOTOXICITY OF HUMAN NATURAL-KILLER-CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 17:53:28